SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-018837
Filing Date
2015-03-11
Accepted
2015-03-11 16:01:52
Documents
3
Period of Report
2015-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-6335_18k.htm 8-K 24202
2 EX-99.1 a15-6335_1ex99d1.htm EX-99.1 131223
3 GRAPHIC g63351mmi001.jpg GRAPHIC 5233
  Complete submission text file 0001104659-15-018837.txt   163932
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 15692557
SIC: 2834 Pharmaceutical Preparations